Scarica l'app Stockscreener
6.95
8.43%
-0.64
Dopo l'orario di chiusura:
6.95
Passage Bio Inc Borsa (PASG) Ultime notizie
Strategies to average down on Passage Bio Inc.Market Activity Summary & Daily Stock Momentum Reports - Newser
Understanding Passage Bio Inc.’s price movementJuly 2025 Price Swings & AI Based Buy and Sell Signals - Newser
Wedbush Forecasts Strong Price Appreciation for Passage Bio (NASDAQ:PASG) Stock - Defense World
Forecasting Passage Bio Inc. price range with options dataPortfolio Value Summary & Weekly Consistent Profit Watchlists - Newser
Passage Bio (PASG) and the 1,415.15% Upside Potential in Biotech Innovation - AInvest
Wall Street Analysts Believe Passage Bio (PASG) Could Rally 1415.15%: Here's is How to Trade - Zacks Investment Research
Wedbush Increases Passage Bio (NASDAQ:PASG) Price Target to $40.00 - Defense World
Bollinger Band Squeeze Points to Volatility in Passage Bio Inc.July 2025 Summary & Step-by-Step Swing Trade Plans - sundaytimes.kr
Passage Bio Inc. stock volume spike explained2025 Short Interest & Capital Efficiency Focused Ideas - Newser
Identifying reversal signals in Passage Bio Inc.Market Movement Recap & High Conviction Buy Zone Alerts - Newser
Passage Bio (NASDAQ:PASG) Price Target Raised to $40.00 - Defense World
Passage Bio price target lowered to $67 from $260 at Canaccord - MSN
Passage Bio Reports Strong Progress in FTD-GRN Gene Therapy Trial, Extends Cash Runway to 2027 - MyChesCo
Guggenheim Keeps Buy Rating on Passage Bio, PT Down to $10. - AInvest
Canaccord Genuity lowers Passage Bio stock price target to $67 from $260 - Investing.com Canada
Guggenheim lowers Passage Bio stock price target to $10 from $40 - Investing.com
Tick level data insight on Passage Bio Inc. volatility2025 Risk Factors & Safe Capital Allocation Plans - Newser
Leading vs lagging indicators on Passage Bio Inc. performanceMarket Volume Summary & Free Verified High Yield Trade Plans - Newser
Can swing trading help recover from Passage Bio Inc. lossesWeekly Investment Report & Fast Moving Trade Plans - Newser
Wedbush Maintains Outperform Rating for Passage Bio, Raises PT to $40 - AInvest
Real time alert setup for Passage Bio Inc. performanceQuarterly Market Summary & Risk Managed Investment Strategies - Newser
What to do if you’re stuck in Passage Bio Inc.IPO Watch & Accurate Entry and Exit Point Alerts - Newser
Passage Bio Reports Promising Q2 2025 Financial Results - The Globe and Mail
Quant Models Detect Momentum Reversal in Passage Bio Inc.Market Growth Review & Weekly Chart Analysis and Trade Guides - sundaytimes.kr
Passage Bio Reports Second Quarter 2025 Financial Results and Provides Recent Business Highlights - GlobeNewswire
Recovery Setup Building in Passage Bio Inc. Experts Say2025 Technical Overview & Fast Moving Trade Plans - sundaytimes.kr
Can swing trading help recover from Passage Bio Inc. losses [Analyst Upgrade]Real-Time Price Movement Reports - Newser
Passage Bio Reports Q2 2025 Progress and Financials - TipRanks
What moving averages say about Passage Bio Inc.Accurate Forecast System with AI Support - Newser
Why Passage Bio Inc. stock attracts strong analyst attentionSupport Level Bounce Alerts - newsyoung.net
Passage Bio, Inc. shares rise 4.99% after-hours after reporting positive interim data for PBFT02. - AInvest
Passage Bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
Passage Bio Inc reports results for the quarter ended June 30Earnings Summary - TradingView
What makes Passage Bio Inc. stock price move sharplyStock Picks with 300% Gain - kangso.co.kr
Passage BIO, Inc. SEC 10-Q Report - TradingView
Passage Bio Reports Robust FTD-GRN Data, Submits Amended Study Protocol - AInvest
Passage Bio's FTD Drug Shows Breakthrough Results: CSF Biomarker Hits Healthy Range - Stock Titan
Passage Bio Inc. stock outlook for YEARMinimal Risk Growth Investment Opportunity Analysis - Newser
Published on: 2025-08-12 04:09:31 - Newser
Passage Bio PASG 2025Q2 Earnings Preview Downside Risk Amid Revenue Challenges - AInvest
Risk vs reward if holding onto Passage Bio Inc.Predictive Short-Term Market Reversal Alerts - Newser
What analysts say about Passage Bio Inc. stock outlookSummary of Trade Cycles in 5-Year Range - Newser
Technical signs of recovery in Passage Bio Inc.Weekly Hot Stocks Based on Volume Flow - Newser
Sentiment analysis tools applied to Passage Bio Inc.ROI Focused Watchlist with Trade Confidence - Newser
Will Passage Bio Inc. Stock Benefit from AI and Green Energy TrendsAsset Growth Pattern and Return Summary - Newser
Tools to assess Passage Bio Inc.’s risk profileWeekly Breakout Forecast with Entry Zones - Newser
0.41%
0.88%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):